Pembrolizumab Plus Radiotherapy for Advanced Renal Cancer

Clinical trial NCT05567588 · UNKNOWN

Trial details

NCT number: NCT05567588
Sponsor: Nanfang Hospital, Southern Medical University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Clear-cell Metastatic Renal Cell Carcinoma

Start date: 2022-10-31
Primary completion: 2024-10-31
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.